Increased Breast Cancer Risk Following Long-Term Hormone Replacement Therapy
"Are you taking or did you take hormones? If yes, which hormone medication and for how long? When did you stop taking hormone replacement medication?" 3, 464 breast cancer patients and 6, 657 healthy women between the ages of 50 and 74 years participated in a large survey and elicited detailed information about hormone replacement medications they are taking or used to take for relief of menopausal symptoms.
Delayed Sleep Phase Syndrome Linked To Irregular Menstrual Cycles, Premenstrual Symptoms In Women
Women with delayed sleep phase syndrome are more likely to report irregular menstrual cycles and premenstrual symptoms, according to a research abstract presented on Tuesday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).
Estrogen Helps Drive Distinct, Aggressive Form Of Prostate Cancer
Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers.Estrogen-linked signaling helps drive a discrete and aggressive form of the disease caused by a chromosomal translocation, which in turn results in the fusion of two genes.
Aggressive Subclass Of Prostate Cancer May Be Driven By Estrogen Signaling - May 27 JNCI
Aggressive prostate cancers that harbor a particular gene fusion are a distinct molecular subtype of the disease and their growth may be regulated by estrogen signaling.Prostate cancers that carry the TMPRSS2-ERG gene fusion, which links the regulatory region of one gene to the protein-coding region of another, tend to be aggressive.
AACE Launches Website To Promote Patient Safety
The American Association of Clinical Endocrinologists (AACE) announced the launch of a one-of-a-kind resource for patients and their healthcare professionals at its 17th Annual Meeting and Clinical Congress in Orlando, FL. The website, called the Patient Safety Exchange, is now live and free for anyone to use.
Shire Announces Approval Of ELAPRASE R idursulfase In Brazil
Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced that ELAPRASE(R) (idursulfase), a human enzyme replacement therapy for the treatment of Hunter syndrome, has been approved by the Brazilian Regulatory Agency, Agencia Nacional de Vigilancia Sanitaria (ANVISA).
Blood Protein That May Suppress Appetite Increased By Aerobic Exercise
Three months of aerobic exercise decreased body fat and calorie intake in overweight and obese people, according to a new study, and the researchers believe that changes to a central nervous system factor are responsible. The results were presented at The Endocrine Society's 90th Annual Meeting in San Francisco.
New Subset Analysis Of AndroGel R Data Highlights Efficacy - Regardless Of BMI
Solvay Pharmaceuticals, Inc. announced that a new analysis of pivotal study data conducted by the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center showed that initial treatment response of hypogonadal men with AndroGel(R) (testosterone gel) 1% CIII had similar effects on subjects, regardless of weight and body mass index (BMI).
Long-Term Risk Of Death In Men Appears To Be Increased By Low Testosterone
Men may not live as long if they have low testosterone, regardless of their age, according to a new study. The results were presented at The Endocrine Society's 90th Annual Meeting in San Francisco.The new study, from Germany, adds to the scientific evidence linking deficiency of this sex hormone with increased death from all causes over time - so-called "all-cause mortality.
Scientists Find Potential Protein Biomarkers For Growth Hormone
Ohio University scientists have identified several proteins in mice that might act as biomarkers for growth hormone. The research could be the first step to finding a more reliable way to detect recombinant human growth hormone (rhGH), which some athletes and teenagers use illegally to boost muscle and reduce fat.